Discover the World’s Fastest Business Insights
Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.
London-Based Open Banking Solution Vyne Secures £11.3M Funding As It Focuses On Growth
Company Info
Company news
Mon, 06 Jan 2025 08:00:00 GMT
VYNE Therapeutics Completes Enrollment in Phase 2b Trial Evaluating VYN201 for the Treatment of Nonsegmental Vitiligo - Yahoo Finance
Mon, 23 Dec 2024 08:00:00 GMT
VYNE Therapeutics Reports Positive Phase 1a MAD Data for BD2-Selective BET Inhibitor VYN202 - Dermatology Times
Tue, 19 Nov 2024 08:00:00 GMT
VYNE Therapeutics initiated with a Buy at BTIG on I&I potential - Yahoo Finance
Thu, 26 Sep 2024 07:00:00 GMT
We Think VYNE Therapeutics (NASDAQ:VYNE) Needs To Drive Business Growth Carefully - Yahoo Finance
Fri, 10 Mar 2023 08:00:00 GMT
Vyne swings behind BET inhibitors, seeks partner for failed eczema drug - Fierce Biotech
Tue, 31 Oct 2023 23:53:03 GMT
symbol__ Stock Quote Price and Forecast - CNN
Tue, 18 Jan 2022 08:00:00 GMT
Journey of Vyne's topical drugs continues with $20M deal - FiercePharma
Thu, 13 Jan 2022 08:00:00 GMT
Journey Medical Corporation Acquires Two FDA-Approved - GlobeNewswire
Sat, 09 Nov 2024 08:00:00 GMT
VYNE Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Wed, 29 Dec 2021 08:00:00 GMT
New Drugs, Devices Could Revolutionize Pigmentary Treatment - Dermatology Times
Never Miss an Opportunity: Your #1 Sales Intelligence Tool
Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.